Skip to main content
Addgene

MARK2/MARK3 kinases are catalytic co-dependencies of YAP/TAZ in human cancer.

Klingbeil O, Skopelitis D, Tonelli C, Yoshimoto T, Alpsoy A, Panepinto MC, Minicozzi F, Merrill JR, Cafiero AM, Aggarwal D, Russo S, Ha T, Demerdash OE, Wee TL, Spector DL, Lyons SK, Tuveson DA, Cifani P, Vakoc CR
Cancer Discov. 2024 Jul 26. doi: 10.1158/2159-8290.CD-23-1529. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
229396HA-MAP4K1Lentiviral or overpexression of cDNA
229400HA-MAP4K5Lentiviral or overpexression of cDNA
229402HA-MAP4K7Lentiviral or overpexression of cDNA
229403HA-MAP4K4-10ALentiviral or overpexression of cDNA
229404HA-MAP4K4-10DLentiviral or overpexression of cDNA
229405FLAG-MKI-P2A-GFPLentiviral or overpexression of cDNA
229406FLAG-MKI-MUT-P2A-GFPLentiviral or overpexression of cDNA
229407FLAG-MKI-P2A-GFP-DOX-NLentiviral or overpexression of cDNA
229408FLAG-MKI-MUT-P2A-GFP-DOX-NLentiviral or overpexression of cDNA
229410HA-CDC25CLentiviral or overpexression of cDNA
229411HA-TEAD1Lentiviral or overpexression of cDNA
229412HA-YAP-wtLentiviral or overpexression of cDNA
229413HA-YAP-5ALentiviral or overpexression of cDNA
229414HA-TAZ-4ALentiviral or overpexression of cDNA
229415HA-YAP-5DLentiviral or overpexression of cDNA
229416HA-TAZ-4DLentiviral or overpexression of cDNA
229417HA-MST1Lentiviral or overpexression of cDNA
229420HA-MST2-S444ALentiviral or overpexression of cDNA
229422FLAG-MARK3-CRLentiviral or overpexression of cDNA
229423FLAG-MARK2-GK-CRLentiviral or overpexression of cDNA
229424FLAG-MARK3-GK-CRLentiviral or overpexression of cDNA
229425FLAG-MARK2-K82H-CRLentiviral or overpexression of cDNA
229426V5-14-3-3-eLentiviral or overpexression of cDNA
229427HA-MOB1ALentiviral or overpexression of cDNA
229428HA-MOB1BLentiviral or overpexression of cDNA
229429sgMST1/2-1knockout of MST1 and MST2
229430sgMST1/2-2knockout of MST1 and MST2
229431sgLATS1/2-1knockout of LATS1 and LATS2
229432sgLATS1/2-2knockout of LATS1 and LATS2
229434sgMARK2-R-1knockout of MARK2
229435sgMARK2-R-2knockout of MARK2
229436sgMARK2-R-3knockout of MARK2
229437sgMARK3-R-1knockout of MARK3
229439sgMARK3-R-3knockout of MARK3
229440sgMARK2-3-1knockout of MARK2 and MARK3
229441sgMARK2-3-2knockout of MARK2 and MARK3
229442sgMARK2-3-3knockout of MARK2 and MARK3
229443sgCDK1-ROSAknockout of CDK1
229448sgTAZ-R-1knockout of WWTR1 (TAZ)
229449sgTAZ-R-2knockout of WWTR1 (TAZ)
229450sgTAZ-R-3knockout of WWTR1 (TAZ)
229453sgYAP-TAZ-3knockout of YAP1 and WWTR1 (TAZ)

Antibodies from Article